Advanced search
Log in
Forgot password ?
Remember
Or log in with
Google
Twitter
Facebook
Apple
Sign up
Email Registration
Or log in with
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
Markets
Equities
Top Capitalization
United States
North America
Europe
Asia
Middle East
Sector Research
Financial Calendar
Equities Analysis
Most popular
ALPHABET INC.
MICROSOFT CORPORATION
META PLATFORMS, INC.
APPLE INC.
AMAZON.COM, INC.
TESLA, INC.
NVIDIA CORPORATION
Indexes
Homepage
Rankings
Europe
America
Asia
Africa
Index Analysis
Indexes News
S&P 500
DOW JONES
NASDAQ 100
TSX COMP
FTSE 100
DAX
CAC 40
EURO STOXX 50
Currency / Forex
Homepage
Rankings
Currency Cross Rate
Currency Converter
Forex Analysis
Currencies News
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
Commodities
Homepage
Energy
Precious metals
Agriculture
Industrial Metals
Livestock and Cattle
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
Cryptocurrencies
Homepage
Rankings
Charts
Analysis
News
BITCOIN
ETHEREUM
BINANCE COIN
SOLANA
CARDANO
FTX TOKEN
Interest Rates
Homepage
Developed Nations
Emerging Countries
ETFs Rates
ETF
Rankings and News
Advanced Search
News
All News
World
United States
Europe
North America
South America
Asia
Africa
Middle East
Emerging
Companies
All News
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Security Transactions
Earnings reports
New markets
New products
Corporate strategies
Legal risks
Share buybacks
Mergers and acquisitions
Call Transcripts
Guidance
Indexes
Currency / Forex
Commodities
Cryptocurrencies
ETF
Interest Rates
Economy
Themes
Asset Management
Activism
Climate and ESG
Cybersecurity
Geopolitics
Central Banks
Private Equity
Inflation
Business Leaders
Sectors
All our articles
Most Read News
Hot News
Analysis
All Analysis
Must Read
Equities
Indexes
Currencies
Commodities
Cryptocurrencies
Stock Trading Strategies
All
America
Europe
Asia
Our Shows
Shows
World Press Review
Pump & Dump
Must Watch
Satirical Cartoon
Today's Editorial
Crypto Recap
Stock Picks
Portfolios
Virtual Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Watchlists
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Homepage
Momentum stocks
Undervalued stocks
Growth stocks
ESG stocks
Trend-Following Stocks
Quality stocks
Investment Themes
Homepage
The Golden Age of Video Games
The Cannabis Industry
The Vegan Market
Place your bets
US Basketball
Cybersecurity
Rankings
Top Movers
Top Movers
Unusual volumes
New Historical Highs
New Historical Lows
Long Term
Top Fundamentals
Top Fundamentals
Sales growth
Earnings Growth
Profitability
Finances
Rankings Valuation
Rankings Valuation
P/E ratio
Enterprise value
Yield
Top Consensus
Top Consensus
Analyst Opinion
Target price
Estimates Revisions
Divergence
Top Technicals
Top RSI
Unusual volumes
GAPS
STIM
Breakouts
Trends
Volatility
Top ranking ESG
Top ranking ESG
Environnement
Social
Gouvernance
Rankings Coverage
Screeners
Stock Screener Home
Investment Themes
Ageing Population
Water
The Cannabis Industry
In Vino Veritas
Europe's family businesses
Hydrogen
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Low valuations
My Screeners
All my stocks
Watchlists
Virtual Portfolios
Tools
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Dynamic Chart
Financial Calendar
Economic Calendar
Currency Converter
ProRealTime Trading
Our Services
Our subscriptions
Our Stock Picks
Stock Screener
Thematic Investment Lists
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Homepage
Equities
United States
Nasdaq
Novavax, Inc.
News
Summary
NVAX
US6700024010
NOVAVAX, INC.
(NVAX)
Add to my list
Report
Delayed Nasdaq -
04:00:00 2023-01-27 pm EST
11.29
USD
+2.82%
01/26
FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/26
Novavax needs 6 months to produce annual COVID shots that match new variants
RE
01/25
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
PR
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Funds
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
MarketScreener Strategies
Most relevant news about NOVAVAX, INC.
01/26
FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/25
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
PR
01/20
River Private Wealth announces new round of investment in Novavax, Inc
AQ
01/20
Novavax, Inc. announced that it has received $6.75 million in funding from River Privat..
CI
01/18
Novavax Says South Korea Partner Obtained Approval for Use of COVID-19 Vaccine as Adult..
MT
01/18
Novavax COVID-19 Jab Gets South Korea's OK as Booster for Adults
MT
01/18
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
PR
01/09
Transcript : Novavax, Inc. Presents at 41st Annual J.P. Morgan Healthcare Con..
CI
01/09
Novavax Appoints John Jacobs as CEO
MT
01/09
Novavax's longtime CEO Stanley Erck to retire
RE
01/09
Novavax Names John C. Jacobs as New President & Chief Executive Officer
PR
01/09
Novavax, Inc. Announces Management Changes
CI
01/09
Novavax, Inc. Announces Chief Executive Officer Changes
CI
01/09
Novavax CEO Stanley Erck to retire
RE
01/09
Novavax : to Participate in the 41st Annual J.P. Morgan Healthcare Conference
PU
More most relevant news
All news about NOVAVAX, INC.
01/26
FDA advisers back the same COVID vaccine for initial shots, boosters
RE
01/26
Novavax needs 6 months to produce annual COVID shots that match new variants
RE
01/25
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
PR
01/20
River Private Wealth announces new round of investment in Novavax, Inc
AQ
01/20
Novavax, Inc. announced that it has received $6.75 million in funding from River Privat..
CI
01/18
Novavax Says South Korea Partner Obtained Approval for Use of COVID-19 Vaccine as Adult..
MT
01/18
Novavax COVID-19 Jab Gets South Korea's OK as Booster for Adults
MT
01/18
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
PR
01/10
MarketScreener's World Press Review: January 10
01/10
North American Morning Briefing: More Hawkish Fed -2-
DJ
More news
News in other languages on NOVAVAX, INC.
01/26
Novavax busca un período de 6 meses para producir vacunas COVID que coincidan con las n..
01/18
Novavax déclare que son partenaire sud-coréen a obtenu l'autorisation d'utiliser le vac..
01/18
Novavax COVID-19 Jab reçoit l'aval de la Corée du Sud en tant que rappel pour les adult..
01/18
Novavax : approbation du vaccin Covid comme rappel en Corée
01/13
ANALYSEN DES TAGES von Dow Jones Newswires (13.01.2023)
01/10
Presse Rundblick - Dienstag, 10. Januar
01/10
4 minutos de mercados del martes 10 de enero
01/10
Cronache di Borsa - Martedì 10 gennaio
01/10
CUREVAC, NOVAVAX : grand remaniement des directions, embauches chez San..
01/10
AstraZeneca prend CinCor, Apple abandonne Broadcom ..
More news
Analyst Recommendations on NOVAVAX, INC.
01/09
B. Riley Lowers Novavax's Price Target to $37 From $74, Keeps Buy Rating
MT
2022
B. Riley Lowers Novavax's Price Target to $74 From $83, Keeps Buy Rating
MT
2022
B. Riley Lowers Novavax's PT to $83 From $126 to Reflect Current Realities of COVID Boo..
MT
2022
JPMorgan Downgrades Novavax to Underweight from Neutral, Adjusts Price Target to $27 fr..
MT
2022
B. Riley Securities Lowers Novavax's Price Target to $126 from $171 After Lower-than-Ex..
MT
More recommendations
Press releases
01/25
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
PR
01/20
River Private Wealth announces new round of investment in Novavax, Inc
AQ
01/18
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
PR
01/09
Novavax Inc : Change in Directors or Principal Officers, Regulation FD Disclosure, Financi..
AQ
01/09
Novavax Names John C. Jacobs as New President & Chief Executive Officer
PR
More press releases
Powered by Scoopnest.com
Analysis
Novavax cuts full-year revenue forecast
More Must read
Upcoming event on NOVAVAX, INC.
02/27/23
FY 2022 Earnings Release (Projected)
Company calendar
Upcoming sector events
02/09/23
ALNYLAM PHARMACEUTICALS, INC. : FY 2022 Earnings Release (Projected)
02/10/23
IQVIA HOLDINGS INC. : FY 2022 Earnings Release
02/15/23
SEAGEN INC. : FY 2022 Earnings Release
02/23/23
MODERNA, INC. : FY 2022 Earnings Release (Projected)
More events
Sector
Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research
Slave